LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,204,000 | +28.1% | 1,463,262 | +13.2% | 0.01% | +33.3% |
| Q1 2019 | $7,184,000 | -13.4% | 1,292,130 | +3.4% | 0.01% | -25.0% |
| Q4 2018 | $8,297,000 | -40.0% | 1,249,590 | -3.6% | 0.01% | -33.3% |
| Q3 2018 | $13,827,000 | +691250.0% | 1,295,910 | +974268.4% | 0.01% | – |
| Q2 2018 | $2,000 | +100.0% | 133 | +9.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 122 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -96.8% | 122 | -95.2% | 0.00% | – |
| Q3 2017 | $31,000 | -16.2% | 2,554 | +13.6% | 0.00% | – |
| Q2 2017 | $37,000 | +42.3% | 2,249 | +22.4% | 0.00% | – |
| Q1 2017 | $26,000 | – | 1,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $37,033,000 | 100.00% |
| Artal Group S.A. | 58,274,650 | $499,413,000 | 6.25% |
| SECTOR GAMMA AS | 854,592 | $7,324,000 | 1.32% |
| NEA Management Company, LLC | 2,382,286 | $20,416,000 | 0.91% |
| Virtus ETF Advisers LLC | 89,845 | $770,000 | 0.67% |
| Malaga Cove Capital, LLC | 59,701 | $512,000 | 0.28% |
| MARSHALL WACE, LLP | 736,545 | $6,312,000 | 0.26% |
| USS Investment Management Ltd | 2,741,942 | $22,607,000 | 0.25% |
| CLEARBRIDGE, LLC | 1,172,117 | $10,045,000 | 0.22% |
| WEDBUSH SECURITIES INC | 155,396 | $1,332,000 | 0.17% |